Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Extending the annual screen by a year for people in England considered to be at low risk of diabetic eye disease (diabetic retinopathy) could risk critical treatment delays and/or sight loss, suggests a large, real world data study, published online in the British Journal of Ophthalmology.

Zephyr AI Secures $111M to Democratize Precision Medicine with Explainable AI

What You Should Know: – Zephyr AI, a healthcare technology company pioneering explainable AI (XAI) for precision medicine, raises $111M in Series A round led

March 15, 2024

LEO-152020 by Leo Pharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 28, 2023

The Importance of ‘Privacy and Security by Design’ in Healthcare

Chris Bowen, founder and CISO at ClearDATA In healthcare, sensitive data comes with great responsibility. For companies entrusted with managing and protecting patients’ personal information,

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.